Tau PET Imaging in Atypical Dementias

Trial Profile

Tau PET Imaging in Atypical Dementias

Phase of Trial: Phase I

Latest Information Update: 11 Apr 2018

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Primary progressive aphasia
  • Focus Diagnostic use
  • Most Recent Events

    • 03 Apr 2018 Planned End Date changed from 1 Nov 2022 to 1 Feb 2023.
    • 03 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2022.
    • 14 Nov 2017 Planned number of patients changed from 10 to 70.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top